METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Clinical trials for METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Four-Pronged attack on Tough-to-Treat colon cancer
Disease control OngoingThis study is testing a new combination of four drugs for people with a common type of advanced colorectal cancer that has spread. The goal is to find the safest and most effective dose and see if this four-drug approach can help control the cancer. It combines standard chemother…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
New triple attack on tough colon cancer shows promise
Disease control OngoingThis study is testing a combination of three drugs (encorafenib, cetuximab, and nivolumab) for people with advanced colorectal cancer that has a specific BRAF gene mutation and has spread or cannot be removed by surgery. The goal is to find the safest dose and see if the three dr…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New drug duo aims to halt spread of tough colon cancer
Disease control OngoingThis study is testing if two drugs, niraparib and panitumumab, work better together to treat advanced colorectal cancer that has spread. It involves about 26 people whose cancer has continued to grow despite prior treatment. The main goals are to see if the combination can stop o…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
New hope for Tough-to-Treat colon cancer: trial tests Triple-Threat therapy
Disease control OngoingThis trial is testing a new combination of three drugs for people with a common type of advanced colon cancer that has spread and is no longer responding to standard chemotherapy. The goal is to see if two immunotherapy drugs that help the immune system attack cancer, combined wi…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 09, 2026 14:22 UTC